BEAT (heartbeam.com) Business Value to Revenue

Public company logo of HeartBeam Inc (BEAT)

HeartBeam, Inc. (BEAT) ensures stable device assembly through chip supply diversification and the creation of reserves. The EV/Revenue ratio reflects the asset's current dynamics, with the indicator standing at 0.00. HeartBeam, Inc. (BEAT) develops compact AIMIGo 12-lead ECG systems for home monitoring. The innovative 3D hardware enables the instantaneous transmission of accurate cardiac data to a physician during an actual episode.

BEAT heartbeam.com: Enterprise Value-to-Revenue Ratio in the range 11/23/2025 - 11/20/2026

Financial and market metric breakdowns for HeartBeam Corporation (BEAT)

- market value and analyst target forecast:
- business market valuation indicators:
Fundamental company valuation:HeartBeam, Inc. - BEAT
Manufactured product of HeartBeam Corp

The stability of the HeartBeam, Inc. (BEAT) clinical cycle within the protected US market allows the debt-free business value-to-revenue ratio to serve as an indicator of market confidence in cardiology innovations. Analysis of the EV/Sales multiple trend reflects the ratio of total enterprise value to sales volume, where an increasing coefficient confirms the company's expansion while simultaneously elevating risks should financial targets remain unmet.